Ending Medi-Cal coverage of GLP-1s is short-sighted thinking

Ending Medi-Cal coverage of GLP-1s is short-sighted thinking

Modern GLP-1 medicines are evidence-based therapies that help patients achieve meaningful, sustained weight loss and reduce the risk of heart disease, type 2 diabetes, stroke and orthopedic complications. For many patients, these medications can change the course of their health and prevent the very surgeries I perform.Continue reading the full article: Capitol WeeklyOriginal article: http://capitolweekly.net/ending-medi-cal-coverage-of-glp-1s-i…